BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
15 results:

  • 1. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia.
    Pepeler MS; Tıglıoglu M; Dagdas S; Ozhamamcıoglu E; Han U; Albayrak A; Aydın MS; Korkmaz G; Pamukcuoğlu M; Ceran F; Albayrak M; Ozet G
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e161-e167. PubMed ID: 38342726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Treatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer.
    Shimomura Y; Sawa K; Imai T; Ihara Y; Yoshida H; Shintani A
    Cancer Sci; 2024 Mar; 115(3):926-936. PubMed ID: 38148717
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinicopathological features of mature T/NK cell lymphoma with aberrant CD20 or CD79α expression].
    Li DJ; Kang H; Zhang L; Xu ZG; Wang XY; Wang LF; Song XX; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):413-418. PubMed ID: 35511636
    [No Abstract]    [Full Text] [Related]  

  • 4. Radiomic Features of
    Zhou Y; Zhu Y; Chen Z; Li J; Sang S; Deng S
    Contrast Media Mol Imaging; 2021; 2021():6347404. PubMed ID: 34887712
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
    Zayac AS; Evens AM; Danilov A; Smith SD; Jagadeesh D; Leslie LA; Wei C; Kim SH; Naik S; Sundaram S; Reddy N; Farooq U; Kenkre VP; Epperla N; Blum KA; Khan N; Singh D; Alderuccio JP; Godara A; Yazdy MS; Diefenbach C; Rabinovich E; Varma G; Karmali R; Shao Y; Trabolsi A; Burkart M; Martin P; Stettner S; Chauhan A; Choi YK; Straker-Edwards A; Klein A; Churnetski MC; Boughan KM; Berg S; Haverkos BM; Orellana-Noia VM; D'Angelo C; Bond DA; Maliske SM; Vaca R; Magarelli G; Sperling A; Gordon MJ; David KA; Savani M; Caimi P; Kamdar M; Lunning MA; Palmisiano N; Venugopal P; Portell CA; Bachanova V; Phillips T; Lossos IS; Olszewski AJ
    Haematologica; 2021 Jul; 106(7):1932-1942. PubMed ID: 33538152
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical characteristics and prognosis of Waldenström's macroglobulinemia: a clinical data report from a single center].
    Jia YC; Lu J; Qiang WT; Li L; Liu J; Jiang H; Fu WJ; Du J
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1020-1024. PubMed ID: 33445850
    [No Abstract]    [Full Text] [Related]  

  • 7. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
    Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
    Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical characteristics and prognostic analysis of pediatric pro-B cell acute lymphoblastic leukemia].
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1286-1294. PubMed ID: 33327999
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Prognostic value of international prognostic index, revised international prognostic index, enhanced international prognostic index and Grupo Español de Linfomas/trasplante autólogo de médula ósea-international prognostic index for diffuse large B-cell lymphoma].
    Feng YX; Su LP
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):949-954. PubMed ID: 33256307
    [No Abstract]    [Full Text] [Related]  

  • 10. Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients.
    Pierzynski JA; Ye Y; Lippman SM; Rodriguez MA; Wu X; Hildebrandt MAT
    Sci Rep; 2018 Jul; 8(1):10640. PubMed ID: 30006595
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Prognostic Significance of Joint Detection of miR-210 and Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia].
    Mei YY; Li ZG; Zhang Y; Zhang WL; Zhang PW; Wang N; Huang DS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):66-71. PubMed ID: 28245377
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma.
    He E; Xu XH; Guan H; Chen Y; Chen ZH; Pan ZL; Tang LL; Hu GZ; Li Y; Zhang M; Zhou J; Eriksson S; Fornander T; Skog S
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):352-8. PubMed ID: 20544519
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Efficacy of vinblastine, bleomycin, methotrexate (VBM) combination chemotherapy with involved field radiotherapy in early stage (I-IIA) Hodgkin disease patients.
    Martinelli G; Cocorocchio E; Saletti PC; Orecchia R; Bernier J; Tradati N; Santoro P; Robertson C; Peccatori FA; Zucca E; Cavalli F
    Leuk Lymphoma; 2003 Nov; 44(11):1919-23. PubMed ID: 14738143
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
    Mathé G; Misset JL; Machover D; Schwarzenberg L; Timus M; Jasmin C; Ribaud P; Musset M
    Biomed Pharmacother; 1984; 38(1):13-32. PubMed ID: 6380605
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.